Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)

NCT02866916 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study cancelled

Conditions

Prostatic Cancer, Castration-Resistant

Interventions

DRUG: SXL01

Sponsor

Institut Claudius Regaud